ArticleJournal of magnetic resonance imaging : JMRI2026
Quantification of Tricuspid Valve Regurgitation With 2D and 4D-Flow MRI: Comparison of Different Methods in Adult Patients With Ebstein's Anomaly.
Article in Journal of magnetic resonance imaging : JMRI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundEbstein's anomaly (EA) is a congenital heart disorder involving tricuspid valve dysplasia and right heart abnormalities resulting in severe tricuspid regurgitation (TR). Multiple techniques assess regurgitation severity, but their correlation with EA severity markers remains unclear. PURPOSE: To compare MRI techniques for quantifying TR and regurgitant volume (RVol) in adults with EA. STUDY TYPE: Retrospective. SUBJECTS: Thirty-three adult patients with EA (15 males/18 females). FIELD STRENGTH/SEQUENCE: 3T or 1.5-Tesla, 2D-phase contrast (2D-PC gradient echo) and 4D-flow (gradient echo). ASSESSMENT: RVol was measured using three methods: (1) 2D-indirect: subtraction of systolic pulmonary artery (PA) forward flow (2D-PC) from functional right ventricular stroke volume (fRVSV); (2) 4D-indirect: subtraction of PA systolic forward flow from tricuspid diastolic forward flow using 4D-flow; (3) 4D-direct: direct jet measurement with 4D-flow. Correlations were evaluated between RVol and severity markers (left ventricular ejection fraction [LVEF], functional right ventricular end-diastolic volume [fRVEDV], fRV/LV ratio, severity index volume, total right/left volume index, fRVEF). STATISTICAL TESTS: Pearson or Spearman correlation coefficients (p < 0.05) significant.
resultsThe 4D-direct method had the highest correlation with the mean RVol (2D-indirect: r = 0.93, 4D-indirect: r = 0.93; 4D-direct: r = 0.95) and with severity markers: total right/left volume index (0.84, 0.64, 0.87), the fRVEDV (0.66, 0.58, 0.71), fRV/LVratio (0.81, 0.75, 0.87), and severity index volume (0.45, 0.59, 0.66). DATA
conclusion4D-flow enables intrinsic RVol quantification independent of fRV segmentation, with the direct jet method outperforming indirect approaches. LEVEL OF EVIDENCE: 3: TECHNICAL EFFICACY: Stage 2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.